JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
Investing.com - Tenet Healthcare (NYSE: THC) reported fourth quarter EPS of $3.44, $0.49 better than the analyst estimate of $2.95. Revenue for the quarter came in at $5.07B versus the consensus estimate of $5.17B.
Guidance
Tenet Healthcare sees FY 2025 EPS of $11.74-$12.84 versus the analyst consensus of $11.08.
Tenet Healthcare sees FY 2025 revenue of $20.60B-$21.00B versus the analyst consensus of $21.30B.
Tenet Healthcare’s stock price closed at $138.83. It is down -10.63% in the last 3 months and up 57.64% in the last 12 months.
Tenet Healthcare saw 11 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Tenet Healthcare’s stock price’s past reactions to earnings here.
According to InvestingPro, Tenet Healthcare’s Financial Health score is "great performance".
Check out Tenet Healthcare’s recent earnings performance, and Tenet Healthcare’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar